Kangasala, Finland

Heikki Nupponen


Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1995-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Heikki Nupponen: Innovator in Pharmaceutical Chemistry

Introduction

Heikki Nupponen is a notable inventor based in Kangasala, Finland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 3 patents to his name, Nupponen continues to push the boundaries of chemical research and development.

Latest Patents

Nupponen's latest patents include groundbreaking work on methylenebisphosphonic acid derivatives. The focus of this invention is on novel halogen substituted methylenebisphosphonic acid anhydrides, ester anhydrides, amide anhydrides, and ester amide anhydrides. These compounds are not only innovative but also have potential applications in pharmaceutical preparations. Additionally, he has developed a process for preparing a clodronate preparation, which further showcases his expertise in the field.

Career Highlights

Heikki Nupponen is associated with Leiras Oy, a company known for its commitment to pharmaceutical advancements. His work at Leiras Oy has allowed him to explore various aspects of chemical innovation, contributing to the development of new therapeutic agents.

Collaborations

Throughout his career, Nupponen has collaborated with esteemed colleagues such as Esko Pohjala and Hannu Hanhijarvi. These collaborations have enriched his research and have led to the successful development of several innovative compounds.

Conclusion

Heikki Nupponen stands out as a prominent figure in pharmaceutical chemistry, with a focus on innovative compounds that have the potential to impact the industry significantly. His contributions through patents and collaborations highlight his dedication to advancing chemical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…